G Schnyder

Summary

Publications

  1. ncbi Decreased rate of coronary restenosis after lowering of plasma homocysteine levels
    G Schnyder
    Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital
    N Engl J Med 345:1593-600. 2001
  2. ncbi Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial
    Guido Schnyder
    Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Switzerland
    JAMA 288:973-9. 2002
  3. ncbi Plasma homocysteine levels and late outcome after coronary angioplasty
    Guido Schnyder
    Division of Cardiology, Medical Center, University of California at San Diego, 200 West Arbor Drive, San Diego, CA 92103 8784, USA
    J Am Coll Cardiol 40:1769-76. 2002
  4. ncbi Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries
    Guido Schnyder
    Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Switzerland
    Am J Cardiol 91:1265-9. 2003
  5. ncbi Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence
    Guido Schnyder
    Division of Cardiology, UCSD Medical Center, University of California, San Diego, California 92103 8784, USA
    Ann Med 35:156-63. 2003
  6. ncbi Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty
    G Schnyder
    Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Eur Heart J 23:726-33. 2002
  7. ncbi Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies
    G Schnyder
    Division of Cardiology, UCSD Medical Center, University of California, 200 West Arbor Drive, San Diego, CA 92103, USA
    Catheter Cardiovasc Interv 53:289-95. 2001
  8. ncbi Concomitant coronary and multiple arch vessel stenoses in patients treated with external beam radiation: pathophysiological basis and endovascular treatment
    Jeffrey J Cavendish
    Division of Cardiology, University of California, San Diego, California, USA
    Catheter Cardiovasc Interv 62:385-90. 2004
  9. ncbi Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention
    Ehtisham Mahmud
    Division of Cardiology, University of California at San Diego, San Diego, California 92103 8784, USA
    J Am Coll Cardiol 49:2163-71. 2007

Collaborators

Detail Information

Publications9

  1. ncbi Decreased rate of coronary restenosis after lowering of plasma homocysteine levels
    G Schnyder
    Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital
    N Engl J Med 345:1593-600. 2001
    ..We designed this study to evaluate the effect of lowering plasma homocysteine levels on restenosis after coronary angioplasty...
  2. ncbi Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial
    Guido Schnyder
    Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Switzerland
    JAMA 288:973-9. 2002
    ....
  3. ncbi Plasma homocysteine levels and late outcome after coronary angioplasty
    Guido Schnyder
    Division of Cardiology, Medical Center, University of California at San Diego, 200 West Arbor Drive, San Diego, CA 92103 8784, USA
    J Am Coll Cardiol 40:1769-76. 2002
    ..The aim of this study was to evaluate a possible relationship between homocysteine levels on admission and late outcome after successful percutaneous coronary intervention (PCI)...
  4. ncbi Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries
    Guido Schnyder
    Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Switzerland
    Am J Cardiol 91:1265-9. 2003
  5. ncbi Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence
    Guido Schnyder
    Division of Cardiology, UCSD Medical Center, University of California, San Diego, California 92103 8784, USA
    Ann Med 35:156-63. 2003
    ..Restenosis after percutaneous coronary angioplasty (PTCA) remains an important limitation of this procedure...
  6. ncbi Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty
    G Schnyder
    Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Eur Heart J 23:726-33. 2002
    ..Thus, plasma homocysteine appears to be an important cardiovascular risk factor influencing outcome after successful coronary angioplasty...
  7. ncbi Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies
    G Schnyder
    Division of Cardiology, UCSD Medical Center, University of California, 200 West Arbor Drive, San Diego, CA 92103, USA
    Catheter Cardiovasc Interv 53:289-95. 2001
    ..Puncture above the femoral head center and below the superior margin of the acetabulum accurately predicts an ideal puncture site. Thus, routine fluoroscopic guidance should be considered. Cathet Cardiovasc Intervent 2001;53:289-295...
  8. ncbi Concomitant coronary and multiple arch vessel stenoses in patients treated with external beam radiation: pathophysiological basis and endovascular treatment
    Jeffrey J Cavendish
    Division of Cardiology, University of California, San Diego, California, USA
    Catheter Cardiovasc Interv 62:385-90. 2004
    ..We review the pathophysiology, discuss the treatment options and describe the percutaneous treatment of coronary, carotid, subclavian, and axillary stenoses related to this rare but likely underdiagnosed disorder...
  9. ncbi Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention
    Ehtisham Mahmud
    Division of Cardiology, University of California at San Diego, San Diego, California 92103 8784, USA
    J Am Coll Cardiol 49:2163-71. 2007
    ..This study sought to determine the factors associated with suboptimal platelet inhibition (PI) with single- and double-bolus eptifibatide during percutaneous coronary intervention (PCI)...